Torna al Registre Simple

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorLehnert, Thomas
dc.contributor.authorRöver, Christian
dc.contributor.authorKöpke, Sascha
dc.contributor.authorRio Izquierdo, Jordi
dc.contributor.authorFittipaldo, Andrea Veronica
dc.contributor.authorChard, Declan
dc.date.accessioned2022-09-13T10:45:57Z
dc.date.available2022-09-13T10:45:57Z
dc.date.issued2022-07-01
dc.identifier.citationLehnert T, Röver C, Köpke S, Rio J, Chard D, Fittipaldo AV, et al. Immunotherapy for people with clinically isolated syndrome or relapsing-remitting multiple sclerosis: treatment response by demographic, clinical, and biomarker subgroups (PROMISE)—a systematic review protocol. Syst Rev. 2022 Jul 1;11:134.
dc.identifier.issn2046-4053
dc.identifier.urihttps://hdl.handle.net/11351/8182
dc.descriptionImmunoteràpia; Esclerosi múltiple; Resposta al tractament
dc.description.sponsorshipOpen Access funding enabled and organized by Projekt DEAL. Federal Ministry of Education and Research (BMBF), Germany (grant 01KG1804). The funding body had no influence on the design of the protocol.
dc.language.isoeng
dc.publisherBMC
dc.relation.ispartofseriesSystematic Reviews;11
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectEsclerosi múltiple - Tractament
dc.subjectMarcadors bioquímics
dc.subjectImmunitat
dc.subject.meshMultiple Sclerosis, Relapsing-Remitting
dc.subject.mesh/therapy
dc.subject.meshImmunologic Factors
dc.subject.meshBiomarkers
dc.titleImmunotherapy for people with clinically isolated syndrome or relapsing-remitting multiple sclerosis: treatment response by demographic, clinical, and biomarker subgroups (PROMISE)—a systematic review protocol
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1186/s13643-022-01997-2
dc.subject.decsesclerosis múltiple recurrente-remitente
dc.subject.decs/terapia
dc.subject.decsfactores inmunitarios
dc.subject.decsbiomarcadores
dc.relation.publishversionhttps://doi.org/10.1186/s13643-022-01997-2
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Lehnert T] Institute of Neuroimmunology and Multiple Sclerosis, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany. [Röver C] Department of Medical Statistics, University Medical Center Göttingen, Göttingen, Germany. [Köpke S] Institute of Nursing Science, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany. [Rio J] Servei de Neurologia-Neuroimmunologia, Centre d’Esclerosi Multiple de Catalunya (CEMCAT), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Chard D] Department of Neuroinfammation, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK. National Institute for Health Research (NIHR), University College London Hospitals (UCLH) Biomedical Research Centre, London, UK. [Fittipaldo AV] Department of Oncology, Istituto Ricerche Farmacologiche “Mario Negri” IRCCS, Milano, Italy
dc.identifier.pmid35778721
dc.identifier.wos000819782500002
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Fitxers en aquest element

Thumbnail

Aquest element apareix en la col·lecció o col·leccions següent(s)

Torna al Registre Simple